Market Overview

UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on XenoPort

Related XNPT
Benzinga's M&A Chatter for Monday May 23, 2016
Mid-Afternoon Market Update: KLX Drops On Q1 Results; Resource America Shares Spike Higher

In a report published Friday, Deutsche Bank reiterated its Buy rating on XenoPort (NASDAQ: XNPT), and raised its price target from $10.00 to $12.00.

Deutsche Bank noted, “Maintain Buy following positive initial clinical data for XP'829. XenoPort's transporter technology platform potentially offers a deep pipeline of opportunities, including XP'986 for spasticity, XP'829 (“BG12” like compound), and recently launched Regnite (Astellas) in Japan, etc. Hence, we continue to view XenoPort as an attractive investment opportunity despite the ongoing dispute over Horizant with GSK.”

XenoPort closed on Thursday at $11.15.

Latest Ratings for XNPT

Jan 2016Credit SuisseMaintainsUnderperform
Jan 2016Credit SuisseInitiates Coverage onUnderperform
Jan 2015JefferiesMaintainsBuy

View More Analyst Ratings for XNPT
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings


Related Articles (XNPT)

View Comments and Join the Discussion!